Publication
Number of items: 7.
None
Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone. (2004)
A. Mantyla,
T. Garnier,
J. Rautio,
T. Nevalainen,
J. Vepsalainen,
A. Koskinen,
S.L. Croft
and
T. Jarvinen
CCR2: Characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach. (2003)
Theo Berkhout,
F.E. Blaney,
A.M. Bridges,
D.G. Cooper,
I.T. Forbes,
A.D. Gribble,
P.H.E. Groot,
A. Hardy,
R.J. Ife,
R. Kaur,
K.E. Moores,
H. Shillito,
J. Willetts
and
J. Witherington
A New Pyridazine Series of GABAA α5 Ligands. (2005)
M.B. Van Niel,
K. Wilson,
C.H. Adkins,
J.R. Atack,
J.L. Castro,
D.E. Clarke,
S. Fletcher,
U. Gerhard,
M.M. Mackey,
S. Malpas,
K. Maubach,
R. Newman,
D. O'Connor,
G.V. Pillai,
P.B. Simpson,
S.R. Thomas
and
A.M. MacLeod
Selective substrate-based inhibitors of mammalian dimethylarginine dimethylaminohydrolase. (2005)
S. Rossiter,
C.L. Smith,
M. Malaki,
M. Nandi,
H. Gill,
J.M. Leiper,
P. Vallance
and
D.L. Selwood
Structure-activity relationships of monomeric C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine (PBD) antitumor agents. (2010)
Dyeison Antonow,
Maciej Kaliszczak,
Gyoung-Dong Kang,
Marissa Coffils,
Arnaud C Tiberghien,
Nectaroula Cooper,
Teresa Barata,
Sibylle Heidelberger,
Colin H James,
Mire Zloh,
Terence C Jenkins,
Anthony P Reszka,
Stephen Neidle,
Sylvie M Guichard,
Duncan I Jodrell,
John A Hartley,
Philip W Howard
and
David E Thurston
Synthesis of DNA-directed pyrrolidinyl and piperidinyl confined alkylating chloroalkylaminoanthraquinones : potential for development of tumor-selective N-oxides. (2006)
Klaus Pors,
Steven D. Shnyder,
Paul H. Teesdale-Spittle,
John A. Hartley,
Mire Zloh,
Mark Searcey
and
Laurence H. Patterson